Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Sayed, Noha H., Fathy, Nevine, Kortam, Mona A., Rabie, Mostafa A., Mohamed, Ahmed F., Kamel, Ahmed S.
Published in Neurotherapeutics (01.01.2020)
Published in Neurotherapeutics (01.01.2020)
Get full text
Journal Article
Ameliorative effect of palonosetron against binge alcohol-induced neurodamage via targeting miR-155/AKT/mTOR/AMPK-mediated autophagic pathway
Saad, Muhammad A.E., Sayed, Rabab Hamed, El-Sahar, Ayman E., Sayed, Noha H., Kortam, Mona A., Fathy, Nevine
Published in Archives of biochemistry and biophysics (01.09.2025)
Published in Archives of biochemistry and biophysics (01.09.2025)
Get full text
Journal Article
LncRNA GAS5 and miR-137 Polymorphisms and Expression are Associated with Multiple Sclerosis Risk: Mechanistic Insights and Potential Clinical Impact
Senousy, Mahmoud A., Shaker, Olfat G., Sayed, Noha H., Fathy, Nevine, Kortam, Mona A.
Published in ACS chemical neuroscience (03.06.2020)
Published in ACS chemical neuroscience (03.06.2020)
Get full text
Journal Article
Correction to: Vildagliptin Attenuates Huntington's Disease Through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Sayed, Noha H., Fathy, Nevine, Kortam, Mona A., Rabie, Mostafa A., Mohamed, Ahmed F., Kamel, Ahmed S.
Published in Neurotherapeutics (01.03.2022)
Published in Neurotherapeutics (01.03.2022)
Get full text
Journal Article